Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+14.2%
5Y CAGR+30.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+14.2%/yr
vs +388.2%/yr prior
5Y CAGR
+30.1%/yr
Recent deceleration
Acceleration
-374.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $84.60M | +42.8% |
| 2024 | $59.25M | +0.5% |
| 2023 | $58.98M | +3.8% |
| 2022 | $56.81M | +22.6% |
| 2021 | $46.35M | +104.5% |
| 2020 | $22.67M | +179.2% |
| 2019 | $8.12M | +8020.0% |
| 2018 | $100000.00 | -49.5% |
| 2017 | $198000.00 | -47.3% |
| 2016 | $376000.00 | - |